Clinical Trials Logo

Clinical Trial Details — Status: Active, not recruiting

Administrative data

NCT number NCT04672668
Other study ID # SHEBA-20-7318-CP-CTIL
Secondary ID
Status Active, not recruiting
Phase
First received
Last updated
Start date December 13, 2020
Est. completion date February 20, 2024

Study information

Verified date December 2020
Source Sheba Medical Center
Contact n/a
Is FDA regulated No
Health authority
Study type Observational [Patient Registry]

Clinical Trial Summary

in our study we are examining the volume flow of the common femoral artery before and after angigraphy of a critical ischemic limb, as a predictor for wound healing after the treatment


Description:

All patients with threatened limbs, that was decided upon to have angioplasty will be asked to sign consent form to participate in this study. Before having the angioplasty, all participants will be examined with ultrasound duplex to determent their common femoral artery volume flow. Day after the angioplasty, they will be reexamined (this is the usual practice) to detriment the new volume flow in the CFA. The participents examinations in the outpatient clinics will be documented and time for healing will be recorded.


Recruitment information / eligibility

Status Active, not recruiting
Enrollment 200
Est. completion date February 20, 2024
Est. primary completion date December 30, 2021
Accepts healthy volunteers No
Gender All
Age group 12 Years to 120 Years
Eligibility Inclusion Criteria: - All patients with threatened limbs, that was decided upon to have angioplasty . Exclusion Criteria: - those who are not willing to sign a consent form to participate in this study

Study Design


Related Conditions & MeSH terms


Intervention

Diagnostic Test:
duplex ultrasound for the common femoral artery
duplex ultrasound for the common femoral artery before and after the angiography

Locations

Country Name City State
Israel Sheba Health Center Ramat Gan

Sponsors (1)

Lead Sponsor Collaborator
Sheba Medical Center

Country where clinical trial is conducted

Israel, 

Outcome

Type Measure Description Time frame Safety issue
Primary wound healing physical examination 12 months